Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Somnolence
Clinical narrative: After 1st dose patient experienced euphoria on the first half after vaccination; cold sweats; digestion problems; pain; fatigue/Long term fatigue for 3 months; chills; Headaches took 3 months to settle down; sleeping an hour and a half per day; Gross chills and sweats, sweats so bad I had to change my clothes and this went on for a few weeks; fuzziness and inability to concentrate; fuzziness and inability to concentrate/My nervous system can't take that much trauma, it was a very traumatic experience; I had to go back and redevelop strategies for cognitive took me 3 to 4 months function; This spontaneous case was reported by a consumer and describes the occurrence of EUPHORIC MOOD (After 1st dose patient experienced euphoria on the first half after vaccination), COLD SWEAT (cold sweats), DYSPEPSIA (digestion problems), PAIN (pain) and SOMNOLENCE (sleeping an hour and a half per day) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031l20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Trauma (brain). Concurrent medical conditions included Allergy (Allergic to coconut.).    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced EUPHORIC MOOD (After 1st dose patient experienced euphoria on the first half after vaccination), COLD SWEAT (cold sweats), DYSPEPSIA (digestion problems), PAIN (pain), FATIGUE (fatigue/Long term fatigue for 3 months) and CHILLS (chills). In 2021, the patient experienced SOMNOLENCE (sleeping an hour and a half per day), HYPERHIDROSIS (Gross chills and sweats, sweats so bad I had to change my clothes and this went on for a few weeks), DISTURBANCE IN ATTENTION (fuzziness and inability to concentrate), FEELING ABNORMAL (fuzziness and inability to concentrate/My nervous system can't take that much trauma, it was a very traumatic experience), CONDITION AGGRAVATED (I had to go back and redevelop strategies for cognitive took me 3 to 4 months function) and HEADACHE (Headaches took 3 months to settle down). At the time of the report, EUPHORIC MOOD (After 1st dose patient experienced euphoria on the first half after vaccination), COLD SWEAT (cold sweats), DYSPEPSIA (digestion problems), PAIN (pain), DISTURBANCE IN ATTENTION (fuzziness and inability to concentrate) and FEELING ABNORMAL (fuzziness and inability to concentrate/My nervous system can't take that much trauma, it was a very traumatic experience) outcome was unknown and SOMNOLENCE (sleeping an hour and a half per day), HYPERHIDROSIS (Gross chills and sweats, sweats so bad I had to change my clothes and this went on for a few weeks), CONDITION AGGRAVATED (I had to go back and redevelop strategies for cognitive took me 3 to 4 months function), FATIGUE (fatigue/Long term fatigue for 3 months), HEADACHE (Headaches took 3 months to settle down) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drug was not reported. It was reported that patient was on history drug unspecified antibiotics and experienced digestive problems. The patient stated that she believe Moderna COVID-19 vaccine referencing to SM102, triggers hormornes/disrupts hormones and overall she had a traumatic experience. Treatment were CBD pills, CBD dream, Allerest children pills (03/16/2021 1 pill at the morning).   This case was linked to US-MODERNATX, INC.-MOD-2021-047995 (E2B Linked Report). This case was linked to MOD-2021-047995 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: HCP info, reporter address, pt ht/wt, race, PMH On 08-Aug-2021: Follow-up information received captured historical conditions, additional events and outcome.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-047995: